These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

243 related articles for article (PubMed ID: 16894026)

  • 1. Predictive validity of proposed remission criteria in first-episode schizophrenic patients responding to antipsychotics.
    Wunderink L; Nienhuis FJ; Sytema S; Wiersma D
    Schizophr Bull; 2007 May; 33(3):792-6. PubMed ID: 16894026
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Remission after first-episode schizophrenia: results of a long-term follow-up.
    Üçok A; Serbest S; Kandemir PE
    Psychiatry Res; 2011 Aug; 189(1):33-7. PubMed ID: 21196051
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Symptomatic remission and cognitive impairment in first-episode schizophrenia: a prospective 3-year follow-up study.
    Chang WC; Ming Hui CL; Yan Wong GH; Wa Chan SK; Ming Lee EH; Hai Chen EY
    J Clin Psychiatry; 2013 Nov; 74(11):e1046-53. PubMed ID: 24330905
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Subjective assessments of the quality of life, well-being and self-efficacy in patients with schizophrenia.
    Chino B; Nemoto T; Fujii C; Mizuno M
    Psychiatry Clin Neurosci; 2009 Aug; 63(4):521-8. PubMed ID: 19531107
    [TBL] [Abstract][Full Text] [Related]  

  • 5. One-year functional outcomes of naturalistically treated patients with schizophrenia.
    Spellmann I; Riedel M; Schennach R; Seemüller F; Obermeier M; Musil R; Jäger M; Schmauß M; Laux G; Pfeiffer H; Naber D; Schmidt LG; Gaebel W; Klosterkötter J; Heuser I; Maier W; Lemke MR; Rüther E; Klingberg S; Gastpar M; Möller HJ
    Psychiatry Res; 2012 Aug; 198(3):378-85. PubMed ID: 22421065
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Relative contribution of antipsychotics, negative symptoms and executive functions to social functioning in stable schizophrenia.
    Rocca P; Montemagni C; Castagna F; Giugiario M; Scalese M; Bogetto F
    Prog Neuropsychopharmacol Biol Psychiatry; 2009 Mar; 33(2):373-9. PubMed ID: 19211031
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Factors involved in outcome and recovery in schizophrenia patients not on antipsychotic medications: a 15-year multifollow-up study.
    Harrow M; Jobe TH
    J Nerv Ment Dis; 2007 May; 195(5):406-14. PubMed ID: 17502806
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Improvement of subjective well-being and enduring symptomatic remission, a 5-year follow-up of first episode schizophrenia.
    de Haan L; Nimwegen Lv; Amelsvoort Tv; Dingemans P; Linszen D
    Pharmacopsychiatry; 2008 Jul; 41(4):125-8. PubMed ID: 18651339
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Remission in patients with first-episode schizophrenia receiving assured antipsychotic medication: a study with risperidone long-acting injection.
    Emsley R; Oosthuizen P; Koen L; Niehaus DJ; Medori R; Rabinowitz J
    Int Clin Psychopharmacol; 2008 Nov; 23(6):325-31. PubMed ID: 18854720
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Plasma homovanillic acid differences in clinical subgroups of first episode schizophrenic patients.
    Baeza I; Castro-Fornieles J; Deulofeu R; de la Serna E; Goti J; Salvà J; Bernardo M
    Psychiatry Res; 2009 Jul; 168(2):110-8. PubMed ID: 19501918
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Oral versus injectable antipsychotic treatment in early psychosis: post hoc comparison of two studies.
    Emsley R; Oosthuizen P; Koen L; Niehaus DJ; Medori R; Rabinowitz J
    Clin Ther; 2008 Dec; 30(12):2378-86. PubMed ID: 19167596
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Patient-based and clinician-based support for the remission criteria in schizophrenia.
    Docherty JP; Bossie CA; Lachaux B; Bouhours P; Zhu Y; Lasser R; Gharabawi GM
    Int Clin Psychopharmacol; 2007 Jan; 22(1):51-5. PubMed ID: 17159460
    [TBL] [Abstract][Full Text] [Related]  

  • 13. One-year outcome and its prediction in first-episode schizophrenia--a naturalistic study.
    Bachmann S; Bottmer C; Schroder J
    Psychopathology; 2008; 41(2):115-23. PubMed ID: 18059113
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Reliability, validity and ability to detect change of the Personal and Social Performance scale in patients with stable schizophrenia.
    Nasrallah H; Morosini P; Gagnon DD
    Psychiatry Res; 2008 Nov; 161(2):213-24. PubMed ID: 18848731
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sociodemographic and clinical factors associated with relapse in schizophrenia.
    Chabungbam G; Avasthi A; Sharan P
    Psychiatry Clin Neurosci; 2007 Dec; 61(6):587-93. PubMed ID: 18081617
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Interest of a new instrument to assess cognition in schizophrenia: The Brief Assessment of Cognition in Schizophrenia (BACS)].
    Bralet MC; Navarre M; Eskenazi AM; Lucas-Ross M; Falissard B
    Encephale; 2008 Dec; 34(6):557-62. PubMed ID: 19081451
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prospective comparison of course of disability in antipsychotic-treated and untreated schizophrenia patients.
    Thirthalli J; Venkatesh BK; Kishorekumar KV; Arunachala U; Venkatasubramanian G; Subbakrishna DK; Gangadhar BN
    Acta Psychiatr Scand; 2009 Mar; 119(3):209-17. PubMed ID: 19053968
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Quality of life and its association with insight, adverse effects of medication and use of atypical antipsychotics in patients with bipolar disorder and schizophrenia in remission.
    Yen CF; Cheng CP; Huang CF; Yen JY; Ko CH; Chen CS
    Bipolar Disord; 2008 Jul; 10(5):617-24. PubMed ID: 18657246
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Stabilization of the internal structure of persistent auditory verbal hallucinations in schizophrenia.
    Chang JS; Yi JS; Ahn YM; Kim JH; Kim YS
    Aust N Z J Psychiatry; 2009 Mar; 43(3):244-51. PubMed ID: 19221913
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Standardized remission criteria in schizophrenia: descriptive validity and comparability with previously used outcome measures.
    Jäger M; Messer T; Laux G; Pfeiffer H; Naber D; Schmidt LG; Gaebel W; Klosterkötter J; Heuser I; Maier W; Lemke MR; Rüther E; Buchkremer G; Gastpar M; Riedel M; Bottlender R; Strauss A; Möller HJ
    Pharmacopsychiatry; 2008 Sep; 41(5):190-5. PubMed ID: 18763221
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.